LeadIQ logo
Learn more at LeadIQ.com

Insights

New Board Members Abeona Therapeutics appointed Bernhardt G. Zeiher, MD, FCCP, FACP and Eric Crombez, MD as new independent members to its Board of Directors, indicating potential for networking and partnership opportunities with individuals with industry expertise and connections.

Partnership with Beacon Therapeutics Abeona Therapeutics entered a partnership with Beacon Therapeutics for evaluating the use of its patented AAV204 capsid in gene therapies, suggesting a collaboration potential to expand product offerings and reach new markets.

Regulatory Update for Pz-cel Abeona Therapeutics shared a regulatory update for its investigational product, prademagene zamikeracel (pz-cel), indicating progress in the development process that could lead to future sales opportunities upon FDA approval.

Underwritten Offering Abeona Therapeutics conducted a successful underwritten offering, raising $75 million, showcasing investor confidence that can boost trust and interest from potential partners or customers in the company's solutions.

Credit Facility for Commercialization Abeona Therapeutics secured a $50 million credit facility to support the commercialization of its therapy, signifying financial stability and growth potential, which could attract investors and contribute to expanding sales operations.

Similar companies to Abeona Therapeutics

Abeona Therapeutics Tech Stack

Abeona Therapeutics uses 8 technology products and services including SAS, SAP, Twitter Emoji (Twemoji), and more. Explore Abeona Therapeutics's tech stack below.

  • SAS
    Business Intelligence
  • SAP
    Customer Relationship Management
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Chart.js
    Javascript Graphics
  • X-Content-Type-Options
    Miscellaneous
  • Concur
    Travel And Expense Management
  • Animate.css
    UI Frameworks
  • Adobe Creative Suite
    Visualisation Software

Media & News

Abeona Therapeutics's Email Address Formats

Abeona Therapeutics uses at least 1 format(s):
Abeona Therapeutics Email FormatsExamplePercentage
FLast@abeonatherapeutics.comJDoe@abeonatherapeutics.com
95%
First.Last@abeonatherapeutics.comJohn.Doe@abeonatherapeutics.com
3%
Last@abeonatherapeutics.comDoe@abeonatherapeutics.com
1%
FirstLast@abeonatherapeutics.comJohnDoe@abeonatherapeutics.com
1%

Frequently Asked Questions

Where is Abeona Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Abeona Therapeutics's main headquarters is located at 6555 Carnegie Avenue Cleveland, OH 44103 US. The company has employees across 6 continents, including North AmericaAfricaEurope.

What is Abeona Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Abeona Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Abeona Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Abeona Therapeutics is a publicly traded company; the company's stock symbol is ABEO.

What is Abeona Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Abeona Therapeutics's official website is abeonatherapeutics.com and has social profiles on LinkedIn.

How much revenue does Abeona Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Abeona Therapeutics's annual revenue reached $35M.

What is Abeona Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Abeona Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abeona Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Abeona Therapeutics has approximately 131 employees across 6 continents, including North AmericaAfricaEurope. Key team members include Chief Executive Officer: J. S.Chief Executive Officer: J. S.Chief People Officer: A. H.. Explore Abeona Therapeutics's employee directory with LeadIQ.

What industry does Abeona Therapeutics belong to?

Minus sign iconPlus sign icon
Abeona Therapeutics operates in the Biotechnology Research industry.

What technology does Abeona Therapeutics use?

Minus sign iconPlus sign icon
Abeona Therapeutics's tech stack includes SASSAPTwitter Emoji (Twemoji)Chart.jsX-Content-Type-OptionsConcurAnimate.cssAdobe Creative Suite.

What is Abeona Therapeutics's email format?

Minus sign iconPlus sign icon
Abeona Therapeutics's email format typically follows the pattern of . Find more Abeona Therapeutics email formats with LeadIQ.

How much funding has Abeona Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Abeona Therapeutics has raised $75M in funding. The last funding round occurred on May 03, 2024 for $75M.

When was Abeona Therapeutics founded?

Minus sign iconPlus sign icon
Abeona Therapeutics was founded in 2015.
Abeona Therapeutics

Abeona Therapeutics

Biotechnology ResearchOhio, United States51-200 Employees

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Prademagene zamikeracel (pz-cel) is Abeona’s investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa. The Company’s fully integrated cell and gene therapy cGMP manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL™ trial, and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features AAV-based gene therapies for ophthalmic diseases with high unmet medical need. Abeona’s novel, next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. 

Section iconCompany Overview

Headquarters
6555 Carnegie Avenue Cleveland, OH 44103 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ABEO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $75M

    Abeona Therapeutics has raised a total of $75M of funding over 13 rounds. Their latest funding round was raised on May 03, 2024 in the amount of $75M.

  • $10M$50M

    Abeona Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $75M

    Abeona Therapeutics has raised a total of $75M of funding over 13 rounds. Their latest funding round was raised on May 03, 2024 in the amount of $75M.

  • $10M$50M

    Abeona Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.